Summary
UnitedHealth Group (UNH) announced its intention to sell its Brazilian operations to a private investor, with the transaction anticipated to close in the first half of 2024. This divestiture is expected to result in a pre-tax charge of approximately $7 billion upon closing. Importantly, the company states that this charge will be excluded from its adjusted earnings, with the majority being non-cash, primarily due to cumulative foreign currency translation losses. While the GAAP net earnings outlook for 2024 will reflect this charge, UNH is reiterating its previously provided adjusted earnings outlook for 2024, signaling confidence in its ongoing operational performance and profitability metrics that exclude such one-time items.
Key Highlights
- 1Divestiture of Brazilian operations to a private investor.
- 2Expected closing of the sale in the first half of 2024, subject to regulatory and other conditions.
- 3Anticipated pre-tax charge of approximately $7 billion upon closing.
- 4The $7 billion charge will be excluded from adjusted earnings.
- 5Majority of the charge is non-cash, primarily due to cumulative foreign currency translation losses.
- 62024 GAAP net earnings outlook will be impacted by the charge.
- 72024 adjusted earnings outlook remains confirmed as previously communicated.
Frequently Asked Questions
UnitedHealth Group expects to record a pre-tax charge of approximately $7 billion upon closing the sale. The majority of this charge is non-cash and is attributed to cumulative foreign currency translation losses. This charge will impact the company's GAAP net earnings outlook for 2024.
No, the company explicitly stated that the expected $7 billion charge will be excluded from its adjusted earnings. This means the operational performance, as measured by adjusted earnings, will not be directly impacted by this divestiture-related charge.
The sale is expected to close in the first half of 2024, contingent upon meeting regulatory and other closing conditions.
The company's GAAP net earnings outlook for 2024 will be negatively impacted by the expected $7 billion charge. However, UnitedHealth Group is reaffirming its previously provided adjusted earnings outlook for 2024, indicating that its core business operations are performing as expected and are not affected by this strategic divestiture.